Oh Kyung Taek, Kim Dongin, You Hyeon Hee, Ahn Yong Sik, Lee Eun Seong
College of Pharmacy, Chung-Ang University, Dongjak-Gu, Seoul, Republic of Korea.
Int J Pharm. 2009 Jul 6;376(1-2):134-40. doi: 10.1016/j.ijpharm.2009.04.021. Epub 2009 Apr 24.
A surface charge-switched polymeric micelle with a pH signal was developed as a drug-carrying nanovehicle for tumor targeting. The micelles (particle size: approximately 85 nm), constructed from poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-lysine-N(epsilon)-(2,3-dimethyl maleic acid)) (PLA-b-PEG-b-PLys-DMA) and formed by self-assembly in an aqueous pH 7.4 solution, consisted of a hydrophobic core (PLA core) and two hydrophilic shells (PEG shell and PLys-DMA shell). An anionic charge can be built on the surface of the micelle at a physiological pH (approximately pH 7.4) due to 2,3-dimethyl maleic acid (DMA). However, DMA becomes chemically dissociated from the micelle under mild acidic conditions (pH 6.5-7.0) such as that found in solid tumors, which results in the formation of a cationic surface due to the poly(L-lysine) (PLys). This pH-triggered switch in surface charge may enhance cellular uptake of micelles to solid tumors, via an adsorptive endocytotic pathway due to the electrostatic interaction between micelles and cells. In addition, blending of the poly(L-histidine) (polyHis) into the hydrophobic core provides a mechanism for endosomal pH-triggered drug-release from the polymeric micelle. These combined properties of the polymeric micelle may aid in tumor-specific drug accumulation and allow it to be used as an effective treatment for tumors.
一种具有pH信号的表面电荷转换聚合物胶束被开发为用于肿瘤靶向的载药纳米载体。这些胶束(粒径:约85 nm)由聚(L-乳酸)-b-聚(乙二醇)-b-聚(L-赖氨酸-N(ε)-(2,3-二甲基马来酸))(PLA-b-PEG-b-PLys-DMA)构建而成,并在pH 7.4的水溶液中通过自组装形成,由一个疏水核心(PLA核心)和两个亲水壳层(PEG壳层和PLys-DMA壳层)组成。由于2,3-二甲基马来酸(DMA),在生理pH(约pH 7.4)下胶束表面可形成阴离子电荷。然而,在诸如实体瘤中发现的温和酸性条件(pH 6.5 - 7.0)下,DMA会从胶束上发生化学解离,这由于聚(L-赖氨酸)(PLys)导致形成阳离子表面。这种表面电荷的pH触发转换可能通过胶束与细胞之间的静电相互作用,经由吸附性胞吞途径增强胶束对实体瘤细胞的摄取。此外,将聚(L-组氨酸)(polyHis)掺入疏水核心提供了一种内体pH触发聚合物胶束药物释放的机制。聚合物胶束的这些综合特性可能有助于肿瘤特异性药物积累,并使其能够用作肿瘤的有效治疗手段。